VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2018 | Promising outlooks for venetoclax combinations for MM

Shaji Kumar, MD, of the Mayo Clinic, Rochester, MN, presents the results of some preclinical and clinical trials investigating the effects of venetoclax in combination with proteasome inhibitors at the 23rd Congress of the European Hematological Association (EHA) 2018, held in Stockholm, Sweden. Dr Kumar discusses the drugs venetoclax has been combined with and the results of these combinations, all of which seem promising regardless of whether the patients had previously been exposed to drugs of the same kind.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter